Clinical research of Zhuangdan Yanshi Decoction combined with dapoxetine hydrochloride in the treatment of premature ejaculation with cholestasis and phlegm disturbance syndrome.
- Author:
Xing-Yun PENG
1
;
Jian-Guo LIU
2
;
Jiao-Jiao LI
2
;
Xiao-Guang MIAO
2
;
Xu ZHANG
2
Author Information
1. The First School of Clinical Medicine， Shaanxi University of Chinese Medicine， Xi' an, Shaanxi 712046, China.
2. Department of Andrology, Shaanxi Provincial Hospital of Chinese Medicine, Xi'an, Shaanxi 710000, China.
- Publication Type:English Abstract
- Keywords:
premature ejaculation;
dapoxetine hydrochloride;
Zhuangdan Yanshi Decoction
- MeSH:
Humans;
Premature Ejaculation/drug therapy*;
Benzylamines/therapeutic use*;
Drugs, Chinese Herbal/therapeutic use*;
Male;
Naphthalenes/therapeutic use*;
Cholestasis/complications*;
Adult;
Benzyl Compounds/therapeutic use*;
Medicine, Chinese Traditional;
Treatment Outcome
- From:
National Journal of Andrology
2025;31(8):732-736
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the clinical efficacy of Zhuangdan Yanshi Decoction combined with dapoxetine hydrochloride in the treatment of premature ejaculation with cholestasis and phlegm disturbance.
METHODS:A total of 120 patients diagnosed with premature ejaculation and treated in the Andrology Outpatient Department of Shaanxi Provincial Hospital of Traditional Chinese Medicine from March to December in 2022 were selected and randomly divided into treatment group and control group, with 60 cases in each group. The incubation period of intravaginal ejaculation (IELT), the Diagnostic Scale of Premature Ejaculation (PEDT), the Premature Ejaculation Assessment Scale (PEP), the 5-item Sexual Function Evaluation of Chinese Premature Ejaculation Patients (CIPE-5) and the improvement of traditional Chinese medicine symptom scores were compared before and after the treatment. And the adverse reactions were recorded as well.
RESULTS:A total of 105 cases were ultimately included, with 55 cases in the treatment group and 50 cases in the control group. Measurable improvements in IELT, PEDT scores, PEP scores, CIPE scores and TCM symptom scores had been found after treatment in both of two groups (P<0.05). Moreover, the improvement in the treatment group was superior to that in the control group (P<0.05). The total effective rate in the treatment group was 89.1%, which was higher than that(84%) in the control group, with no statistically significant difference between the two groups (P>0.05). The incidence of adverse reactions in the treatment group was 9.1%, which was 24% in the control group. There was significantly difference between two groups (P<0.05).
CONCLUSION:The combination therapy with Zhuangdan Yanshi Decoction and dapoxetine hydrochloride for premature ejaculation associated with cholestasis and phlegm disturbance syndrome is definite, and it can reduce the side effects of drugs, which is better than oral dapoxetine hydrochloride alone.
